Viome Stock

www.viome.comHealthcareFounded: 2016Funding to Date: $135.12MM

Viome is a direct-to-consumer healthcare company, predicting and preventing chronic diseases through a deeper understanding of an individual's biology at a molecular level. The company analyzes microbial and human gene expressions (mRNA), with technology to provide individuals with health insights and precision nutrition.

Register for Details

For more details on financing and valuation for Viome, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Viome.

Register Today

Other companies like Viome in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 

News

Viome Life Sciences, a mission-driven, digital health company leveraging precision nutrition to increase health and longevity, announces today additional funding toward its series C financing round.